Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Allergan files INDs for PEP-005 Topical

July 12, 2004

First clinical evidence of antitumor effects induced by taurolidine in glioblastoma

July 9, 2004

ArQule describes lapachone analogues

July 9, 2004

Tyrosine kinase inhibitors patented by Merck KGaA

July 9, 2004

Abbott and Celera form cancer therapeutics collaboration

July 9, 2004

GOG submits IND for Xyotax study in ovarian cancer

July 9, 2004

U.S. phase I trial of Exherin cleared to begin

July 9, 2004

Chiron acquires Sagres Discovery

July 9, 2004

Modulators of tyrosine kinase-mediated signal transduction disclosed in patent

July 8, 2004

Pharmion launches Vidaza

July 8, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...